SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 188 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $2,062,000 | -29.9% | 228,810 | -6.9% | 0.39% | -30.5% |
Q2 2021 | $2,941,000 | -14.0% | 245,718 | -9.9% | 0.56% | -22.6% |
Q1 2021 | $3,418,000 | +615.1% | 272,801 | +789.9% | 0.72% | +511.0% |
Q4 2020 | $478,000 | +133.2% | 30,655 | +41.2% | 0.12% | +93.4% |
Q3 2020 | $205,000 | +0.5% | 21,710 | -4.8% | 0.06% | -14.1% |
Q2 2020 | $204,000 | +46.8% | 22,800 | +4.6% | 0.07% | +22.4% |
Q1 2020 | $139,000 | -20.1% | 21,800 | +4.8% | 0.06% | +11.5% |
Q4 2019 | $174,000 | +58.2% | 20,800 | +71.9% | 0.05% | +44.4% |
Q3 2019 | $110,000 | – | 12,100 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alexandria Capital, LLC | 1,003,725 | $15,663,000 | 1.66% |
Golden State Equity Partners | 123,817 | $1,932,000 | 1.33% |
Rhenman & Partners Asset Management AB | 821,888 | $12,826,000 | 1.05% |
WASATCH ADVISORS LP | 10,072,381 | $157,180,000 | 0.77% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 29,636 | $462,000 | 0.73% |
Ceeto Capital Group, LLC | 80,000 | $1,248,000 | 0.63% |
EMC Capital Management | 48,992 | $765,000 | 0.58% |
Fort Sheridan Advisors LLC | 71,173 | $1,111,000 | 0.54% |
Vanguard Capital Wealth Advisors | 34,680 | $584,000 | 0.54% |
Casdin Capital, LLC | 1,080,000 | $16,853,000 | 0.50% |